Literature DB >> 34294874

Lower synaptic density is associated with psychiatric and cognitive alterations in obesity.

Ruth H Asch1, Sophie E Holmes1, Ania M Jastreboff2, Marc N Potenza1, Stephen R Baldassarri3, Richard E Carson4, Robert H Pietrzak1,5, Irina Esterlis6,7.   

Abstract

Obesity is a serious medical condition that often co-occurs with stress-related psychiatric disorders. It is recognized that the brain plays a key role in the (patho)physiology of obesity and that there is a bidirectional relationship between obesity and psychopathology, yet molecular mechanisms altered in obesity have not been fully elucidated. Thus, we investigated relationships between obesity and synaptic density in vivo using the radioligand [11C]UCB-J (which binds to synaptic glycoprotein SV2A) and positron emission tomography in individuals with obesity, and with or without stress-related psychiatric disorders. Regions of interest were the dorsolateral prefrontal cortex, orbitofrontal cortex, ventromedial, amygdala, hippocampus, and cerebellum. Forty individuals with a body mass index (BMI) ≥ 25 kg/m2 (overweight/obese), with (n = 28) or without (n = 12) psychiatric diagnosis, were compared to 30 age- and sex-matched normal weight individuals (BMI < 25), with (n = 14) or without (n = 16) psychiatric diagnosis. Overall, significantly lower synaptic density was observed in overweight/obese relative to normal weight participants (ηp2 = 0.193, F = 2.35, p = 0.042). Importantly, in participants with stress-related psychiatric diagnoses, we found BMI to be negatively correlated with synaptic density in all regions of interest (p ≤ 0.03), but no such relationship observed for mentally healthy controls (p ≥ 0.68). In the stress-related psychiatric groups, dorsolateral prefrontal cortex synaptic density was negatively associated with measures of worry (r = -0.46, p = 0.01), tension/anxiety (r = -0.38, p = 0.04), fatigue (r = -0.44, p = 0.02), and attentional difficulties (r = -0.44, p = 0.02). In summary, the findings of this novel in vivo experiment suggest compounding effects of obesity and stress-related psychopathology on the brain and the associated symptomatology that may impact functioning. This offers a novel biological mechanism for the relationship between overweight/obesity and stress-related psychiatric disorders that may guide future intervention development efforts.
© 2021. The Author(s), under exclusive licence to American College of Neuropsychopharmacology.

Entities:  

Mesh:

Year:  2021        PMID: 34294874      PMCID: PMC8674236          DOI: 10.1038/s41386-021-01111-5

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  55 in total

Review 1.  Obesity and cardiovascular disease: revisiting an old relationship.

Authors:  Chrysi Koliaki; Stavros Liatis; Alexander Kokkinos
Journal:  Metabolism       Date:  2018-11-03       Impact factor: 8.694

2.  Association between obesity and psychiatric disorders in the US adult population.

Authors:  Gregory E Simon; Michael Von Korff; Kathleen Saunders; Diana L Miglioretti; Paul K Crane; Gerald van Belle; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2006-07

3.  Frontal and subcortical grey matter reductions in PTSD.

Authors:  Daniel C M O'Doherty; Ashleigh Tickell; Will Ryder; Charles Chan; Daniel F Hermens; Maxwell R Bennett; Jim Lagopoulos
Journal:  Psychiatry Res Neuroimaging       Date:  2017-05-19       Impact factor: 2.376

4.  Increased Proinflammatory Cytokines, Executive Dysfunction, and Reduced Gray Matter Volumes In First-Episode Bipolar Disorder and Major Depressive Disorder.

Authors:  Mu-Hong Chen; Zih-Kai Kao; Wan-Chen Chang; Pei-Chi Tu; Ju-Wei Hsu; Kai-Lin Huang; Tung-Ping Su; Cheng-Ta Li; Wei-Chen Lin; Shih-Jen Tsai; Ya-Mei Bai
Journal:  J Affect Disord       Date:  2020-06-03       Impact factor: 4.839

5.  PTSD and obesity in U.S. military veterans: Prevalence, health burden, and suicidality.

Authors:  Elina A Stefanovics; Marc N Potenza; Robert H Pietrzak
Journal:  Psychiatry Res       Date:  2020-06-18       Impact factor: 3.222

6.  Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity.

Authors:  Zachary J Ward; Sara N Bleich; Angie L Cradock; Jessica L Barrett; Catherine M Giles; Chasmine Flax; Michael W Long; Steven L Gortmaker
Journal:  N Engl J Med       Date:  2019-12-19       Impact factor: 91.245

Review 7.  Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome.

Authors:  Ana Elisa Lohmann; Pamela J Goodwin; Rowan T Chlebowski; Kathy Pan; Vuk Stambolic; Ryan J O Dowling
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

Review 8.  From obesity to diabetes and cancer: epidemiological links and role of therapies.

Authors:  Custodia García-Jiménez; María Gutiérrez-Salmerón; Ana Chocarro-Calvo; Jose Manuel García-Martinez; Angel Castaño; Antonio De la Vieja
Journal:  Br J Cancer       Date:  2016-02-23       Impact factor: 7.640

9.  Different spatial patterns of brain atrophy and global functional connectivity impairments in major depressive disorder.

Authors:  Chuanjun Zhuo; Jiajia Zhu; Chunli Wang; Hongru Qu; Xiaolei Ma; Wen Qin
Journal:  Brain Imaging Behav       Date:  2017-12       Impact factor: 3.978

Review 10.  Psychiatric disorders and obesity: A review of association studies.

Authors:  T M Rajan; V Menon
Journal:  J Postgrad Med       Date:  2017 Jul-Sep       Impact factor: 1.476

View more
  3 in total

Review 1.  Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation.

Authors:  Qin Zhang; Kangyu Jin; Bing Chen; Ripeng Liu; Shangping Cheng; Yuyan Zhang; Jing Lu
Journal:  Front Neurosci       Date:  2022-07-06       Impact factor: 5.152

Review 2.  Synaptic Vesicle Glycoprotein 2A: Features and Functions.

Authors:  Rachele Rossi; Shokouh Arjmand; Simone Larsen Bærentzen; Albert Gjedde; Anne M Landau
Journal:  Front Neurosci       Date:  2022-04-28       Impact factor: 5.152

3.  Aberrant impulse control circuitry in obesity.

Authors:  Daniel A N Barbosa; Fiene Marie Kuijper; Jeffrey Duda; Allan R Wang; Samuel C D Cartmell; Sabir Saluja; Tricia Cunningham; Rajat S Shivacharan; Mahendra T Bhati; Debra L Safer; James D Lock; Robert C Malenka; Ricardo de Oliveira-Souza; Nolan R Williams; Murray Grossman; James C Gee; Jennifer A McNab; Cara Bohon; Casey H Halpern
Journal:  Mol Psychiatry       Date:  2022-06-14       Impact factor: 13.437

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.